PetMed Express (PETS) Q1 FY27 earnings call

PetMed Express continued its operational and financial transformation in Q1 FY27, narrowing its net loss significantly due to cost management and the absence of a prior-year impairment charge. The company focused on diversifying customer acquisition, improving efficiency through technology upgrades, and strengthening its balance sheet via a planned sale-leaseback, while navigating a competitive pet health landscape and evaluating an unsolicited acquisition proposal.